BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doldi V, El Bezawy R, Zaffaroni N. MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer. Cancers (Basel) 2021;13:2380. [PMID: 34069147 DOI: 10.3390/cancers13102380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Soares S, Guerreiro SG, Cruz-Martins N, Faria I, Baylina P, Sales MG, Correa-Duarte MA, Fernandes R. The Influence of miRNAs on Radiotherapy Treatment in Prostate Cancer - A Systematic Review. Front Oncol 2021;11:704664. [PMID: 34414113 DOI: 10.3389/fonc.2021.704664] [Reference Citation Analysis]
2 Barnwal SK, Bendale H, Banerjee S. Non-coding RNAs associated with autophagy and their regulatory role in cancer therapeutics. Mol Biol Rep 2022. [PMID: 35534587 DOI: 10.1007/s11033-022-07517-8] [Reference Citation Analysis]
3 Fontana F, Anselmi M, Limonta P. Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression. Cancers (Basel) 2022;14:1614. [PMID: 35406386 DOI: 10.3390/cancers14071614] [Reference Citation Analysis]
4 Ganini C, Amelio I, Bertolo R, Candi E, Cappello A, Cipriani C, Mauriello A, Marani C, Melino G, Montanaro M, Natale ME, Tisone G, Shi Y, Wang Y, Bove P. Serine and one-carbon metabolisms bring new therapeutic venues in prostate cancer. Discov Onc 2021;12. [DOI: 10.1007/s12672-021-00440-7] [Reference Citation Analysis]